Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Business Exposures
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Psilocybin's Potentially Revolutionary Ability To Treat Depression Hinges On FDA Approval – AJNA BioSciences Is Standardizing Raw Materials To Meet Guidelines
Via News Direct
Exposures Product Safety
Tickers SDZNY
Penny Stock Gritstone Bio Hires Advisor To Evaluate Options, Analyst Downgrades Stock As Data 'Insufficient To Excite Many Investors'
Via Benzinga
Exposures Product Safety
Tickers GRTS
IGC Pharma Wins 2 Awards in Phase 1 of NIA's AI PREPARE Challenge, Advancing Alzheimer's Early Prediction Research
Via PRLog
Topics Artificial Intelligence Intellectual Property Regulatory Compliance
Exposures Artificial Intelligence Intellectual Property Legal
Tickers IGC
InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Featured in Post Discussing Nonaddictive Painkillers Designed to Counter Opioid Crisis
Via Investor Brand Network
Exposures Product Safety
Tickers TNXP
Stellantis Recalls Over 154K Jeep Plug-Hybrid SUVs In US Citing Fire Risk
Via Benzinga
Topics Product Recall
Exposures Legal Product Safety
Tickers STLA
Pharma Company Gets FDA Green Light For Next Phase Trial For Tourette Syndrome
Via Benzinga
Exposures Product Safety
Tickers SPRC
George J. Priester Aviation brings generations of luxury to customers through personalized, private aviation that makes travel easy, efficient, and memorable
Via Press Release Distribution Service
Topics Product Recall
Exposures Coal Legal Product Safety
Optimism Around Aquestive As it Moves Forward With Severe Allergy, Baldness Candidate
Via Benzinga
Exposures Product Safety
Tickers AQST INCY LLY PFE
BridgeBio Pharma's Lead Candidate Cuts Mortality, Related Hospitalizations In Patients With Certain Type Of Heart Disease
Via Benzinga
Exposures Product Safety
Tickers BBIO
BioMedNewsBreaks — Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) CEO Joins Expert Panel at Long COVID, RECOVER TLC Workshop
Via Investor Brand Network
Exposures COVID-19 Product Safety
Tickers TNXP
Capricor Therapeutics Is Up Over 100%, Could Rise Even Higher
Via MarketBeat
Exposures Product Safety
Tickers CAPR PEPG SRPT
BYD Recalls Nearly 97K EVs Over Concerns Of Overheating Part, Potential Fire
Via Benzinga
Topics Product Recall
Exposures Legal Product Safety
Tickers BYDDF BYDDY
Why Investors Slammed the Brakes on Toyota Stock Today
Via The Motley Fool
Topics Product Recall
Exposures Legal Product Safety
Tickers TM
Absence of Black Box Warning For Bristol Myers' Schizophrenia Treatment Could Enhance Alzheimer's Psychosis Potential
Via Benzinga
Exposures Product Safety
Tickers ABBV BMY
FDA Removes Clinical Hold On Biomea Fusion's Early-Stage Trials For Potential Diabetes Candidate
Via Benzinga
Exposures Product Safety
Tickers BMEA
FDA Approves Regeneron/Sanofi's Blockbuster Dupixent For Smoker's Lung Disease
Via Benzinga
Exposures Product Safety
Tickers REGN SNY
InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp.’s (NASDAQ: TNXP) Receives New US Patent for Subcutaneous Administration of Zembrace(R) SymTouch(R) to Treat Migraines
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property Product Safety
Tickers TNXP
Regeneron And Sanofi Snag Their $6 Billion-Potential COPD Approval For Dupixent
Via Investor's Business Daily
Exposures Product Safety
Tickers REGN SNY VRNA
Mercedes-Benz, Toyota, Mazda Issue Massive Recalls Over Software Defects: NHTSA Warns Of Fire, Brake And Airbag Risks
Via Benzinga
Topics Product Recall
Exposures Legal Product Safety
Tickers MBGAF MBGYY MZDAF TM
Schizophrenia Treatment Revolution: FDA Approves Bristol Myers Squibb' Cobenfy As New Class Of Treatment In More Than 3 Decades
Via Benzinga
Exposures Product Safety
Tickers BMY PRTC
Bristol-Myers Squibb's Novel Schizophrenia Drug Wins FDA Approval; BMY Stock Signals Breakout
Via Investor's Business Daily
Exposures Product Safety
Tickers BMY
BioMedNewsBreaks — Longeveron Inc. (NASDAQ: LGVN) to Participate at the Cell & Gene Meeting on the Mesa
Via Investor Brand Network
Exposures Product Safety
Tickers LGVN
IBN Coverage: Clene (NASDAQ: CLNN) to Discuss CNM-Au8(R) Data FDA Leadership
Via NewMediaWire
Exposures Product Safety
Tickers CLNN
AstraZeneca's Top-Selling Cancer Drug Tagrisso Receives FDA Green Light For Another Lung Cancer Indication
Via Benzinga
Exposures Product Safety
Tickers AZN
DGE’s 5th Human Factors Engineering and Usability Studies Congress Discusses Ways of Improving User Experience
Via Investor Brand Network
Exposures Product Safety
GM Recalls Over 18K Vans In US Over Brake Fluid Leak Concerns
Via Benzinga
Topics Product Recall
Exposures Legal Product Safety
Tickers GM
Entrepreneur Javid Javdani Builds Community Through Balboa Market
Via Zexprwire
Topics Product Recall
Exposures Legal Product Safety
Stellantis Recalls Nearly 16K Fiat 124 Spider Roadster Vehicles In The US Over Improper Airbag Deployment Concerns
Via Benzinga
Topics Product Recall
Exposures Legal Product Safety
Tickers STLA
FDA Casts Doubt On Use Of Merck, Bristol Myers' PD-1 Cancer Drugs For Certain Type Of Gastric Cancer Patients
Via Benzinga
Exposures Product Safety
Tickers BGNE BMY MRK
Marina Medical Instruments Partners with FAGA to Address Gaps in Surgical Devices
Via Prodigy
Exposures Product Safety
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.